Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.40 |
| ▸ | GRIA1 known ✓ | P42261 | 2/20 | 0.38 |
| ▸ | GRIA2 known ✓ | P42262 | 2/20 | 0.38 |
| ▸ | GRIA3 known ✓ | P42263 | 2/20 | 0.38 |
| ▸ | GRIA4 known ✓ | P48058 | 2/20 | 0.38 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.37 |
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | ALPI | P09923 | 1/20 | 0.40 |
| ▸ | XIAP | P98170 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 5/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | RGS12 | O14924 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL3639234 | 1.00 | CYP1A2 (0.43) | CYP1A2SLC7A5PKMSLC1A3ALPI | |
| SCHEMBL503556 | 0.98 | CYP1A2 (0.44) | CYP1A2SLC7A5PKMSLC1A3ALPI | |
| Histidine SCHEMBL5134200 | 0.83 | CYP3A4 (0.67) | SLC7A5CPB2CYP3A4HIF1A | |
| SCHEMBL17224471 | 0.82 | CYP1A2 (0.44) | CYP1A2SLC7A5PKMSLC1A3ALPI | |
| SCHEMBL358922 | 0.82 | CYP1A2 (0.44) | CYP1A2SLC7A5PKMSLC1A3ALPI | |
| SCHEMBL27974517 | 0.81 | CYP1A2 (0.46) | CYP1A2SLC7A5PKMSLC1A3ALPI | |
| Hydrochloric Acid SCHEMBL14831326 | 0.81 | CYP1A2 (0.43) | CYP1A2SLC7A5PKMSLC1A3ALPI | |
| SCHEMBL4726518 | 0.80 | CYP1A2 (0.45) | CYP1A2SLC7A5PKMSLC1A3ALPI | |
| SCHEMBL44187 | 0.80 | CYP1A2 (0.45) | CYP1A2SLC7A5PKMSLC1A3ALPI | |
| SCHEMBL4727798 | 0.80 | CYP1A2 (0.45) | CYP1A2SLC7A5PKMSLC1A3ALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5252322-A | Skin tanning compositions containing imidazoles | THE GILLETTE COMPANY (US) | 1993-10-12 | — | — | US | claimed |
| EP-4716693-A2 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2026-04-01 | — | — | EP | disclosed |
| WO-2024243322-A9 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| US-20240392009-A1 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX INC (US) | 2024-11-28 | — | — | US | disclosed |
| WO-2024243322-A2 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2024-11-28 | — | — | WO | disclosed |
| WO-2024155803-A2 | IgG Fc VARIANTS WITH REDUCED SELF-ASSOCIATION | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-07-25 | — | — | WO | disclosed |
| US-20230190930-A1 | ANTI-NUCLEOLIN ANTIBODIES | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) | 2023-06-22 | — | — | US | disclosed |
| US-11357849-B2 | Anti-nucleolin antibodies | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) | 2022-06-14 | — | — | US | disclosed |
| EP-2294150-B1 | METHOD FOR DIRT-RESISTANT TREATMENT OF BANK NOTES AND/OR SECURITY PAPERS IN GENERAL | FEDRIGONI SPA (IT) | 2020-05-20 | — | — | EP | disclosed |
| US-20190338036-A1 | ANTIBODY FORMULATIONS | PRECISION DERMATOLOGY, INC. | 2019-11-07 | — | — | US | disclosed |
| US-20080311119-A1 | ANTIBODY FORMULATIONS | BIOGEN IDEC MA INC. (US) | 2008-12-18 | — | — | US | disclosed |
| EP-1853310-A2 | ANTI A BETA ANTIBODY FORMULATION | Elan Pharma International Limited (IE) | 2007-11-14 | — | — | EP | disclosed |
| EP-1841456-A2 | STABILIZED LIQUID POLYPEPTIDE FORMULATIONS | Wyeth (US) | 2007-10-10 | — | — | EP | disclosed |
| US-20060210557-A1 | Stabilized liquid polypeptide formulations | WYETH | 2006-09-21 | — | — | US | disclosed |
| US-20060193850-A1 | Anti a beta antibody formulation | WYETH LLC | 2006-08-31 | — | — | US | disclosed |
| WO-2006083689-A2 | ANTI A BETA ANTIBODY FORMULATION | ELAN PHARMA INTERNATIONAL LIMITED (IE) | 2006-08-10 | — | — | WO | disclosed |
| WO-2006081587-A2 | STABILIZED LIQUID POLYPEPTIDE FORMULATIONS | WYETH (US) | 2006-08-03 | — | — | WO | disclosed |
| EP-0673783-B1 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORP (US) | 2000-07-05 | — | — | EP | disclosed |
| EP-0673783-A2 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | disclosed |
| US-5252322-A | Skin tanning compositions containing imidazoles | THE GILLETTE COMPANY (US) | 1993-10-12 | — | — | US | disclosed |